




High Resolution Spectroscopy and Chemical Shift
Imaging of Hyperpolarized 129Xe Dissolved in the
Human Brain In Vivo at 1.5 Tesla
Madhwesha Rao, Neil J. Stewart, Graham Norquay, Paul D. Griffiths, and Jim M. Wild*
Purpose: Upon inhalation, xenon diffuses into the bloodstream
and is transported to the brain, where it dissolves in various com-
partments of the brain. Although up to five chemically distinct peaks
have been previously observed in 129Xe rat head spectra, to date
only three peaks have been reported in the human head. This study
demonstrates high resolution spectroscopy and chemical shift
imaging (CSI) of 129Xe dissolved in the human head at 1.5 Tesla.
Methods: A 129Xe radiofrequency coil was built in-house and
129Xe gas was polarized using spin-exchange optical pumping.
Following the inhalation of 129Xe gas, NMR spectroscopy was per-
formed with spectral resolution of 0.033 ppm. Two-dimensional
CSI in all three anatomical planes was performed with spectral
resolution of 2.1 ppm and voxel size 20 mm 20 mm.
Results: Spectra of hyperpolarized 129Xe dissolved in the
human head showed five distinct peaks at 188 ppm, 192 ppm,
196 ppm, 200 ppm, and 217 ppm. Assignment of these peaks
was consistent with earlier studies.
Conclusion: High resolution spectroscopy and CSI of hyperpolar-
ized 129Xe dissolved in the human head has been demonstrated. For
the first time, five distinct NMR peaks have been observed in 129Xe
spectra from the human head in vivo. Magn Reson Med 75:2227–
2234, 2016.VC 2016 The Authors Magnetic Resonance in Medicine
published by Wiley Periodicals, Inc. on behalf of International
Society for Magnetic Resonance in Medicine. This is an open
access article under the terms of the Creative Commons Attribu-
tion License, which permits use, distribution and reproduction in
any medium, provided the original work is properly cited.
Key words: hyperpolarized gas; xenon spectroscopy; chemi-
cal shift imaging; human brain spectroscopy
INTRODUCTION
Hyperpolarized (HP) 129Xe MRI has gained interest ever
since the first image was acquired from a biological sam-
ple (1). Xenon, when inhaled into the lungs, dissolves
into the blood by diffusive gas exchange across the alve-
olar–capillary membrane (2–6). The fraction that dis-
solves in the blood is determined by the xenon blood–
gas partition coefficient (7,8), ratio of ventilated airspace
volume to pulmonary blood volume (9), capillary perfu-
sion and alveolar surface-area-to-volume ratio. In the
bloodstream, dissolved HP 129Xe is transported to distal
organs by the systemic blood circulation. The longitudi-
nal relaxation time T1 of HP
129Xe in the human blood is
sufficiently long (6 s to 8 s for arterial-oxygenated blood
and 3 s to 4 s for venous-deoxygenated blood) for it to be
detected in the distal organs (10–13).
Recently, studies involving NMR spectroscopy and
chemical shift imaging (CSI) of HP 129Xe dissolved in the
brain have been conducted in rats (14–17) and in humans
(4,18). Kershaw et al and Nakamura et al (19,20) observed
five peaks in 129Xe spectra from the rat head, which they
attributed to jaw muscle (187–191 ppm), white matter
(191–194 ppm), gray matter (193–197 ppm), fat tissue out-
side the brain (197–201 ppm), and red blood cells (210
ppm). The feasibility of imaging rat brain using HP 129Xe
CSI was demonstrated by Swanson et al (16). Using HP
129Xe, Mazzanti et al (14) explored the possibility of detect-
ing increased brain perfusion and functional activity fol-
lowing sensory stimulation in rats and Zhou et al (15)
demonstrated the detection of ischemic stroke in rats. To
our understanding, the only two studies of HP 129Xe in the
human head to date are from Mugler et al (4) and Kilian
et al (18,21) who presented time resolved spectra depicting
the uptake of HP 129Xe into the human brain in vivo.
Subsequently, Kilian et al (18,21) reported preliminary
results of HP 129Xe CSI in the human brain at 3.0 Tesla (T)
and estimated T1 relaxation of HP
129Xe dissolved in gray
matter and white matter to be 14 s and 8 s, respectively.
Unlike the HP 129Xe studies conducted in rats (19,20),
the preliminary human studies have revealed two dis-
solved peaks which were attributed to gray matter (196
ppm) and white matter (193 ppm) (18,21), and one report
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showed evidence of a third peak at 186 ppm (21). Thus,
the motivation of our study at 1.5T was to perform (i)
high resolution 129Xe spectroscopy of the human head in
vivo and (ii) CSI to spatially resolve the compartments of
the brain responsible for the peaks observed.
METHODS
RF Coil and Calibration
For the construction of a custom 129Xe radiofrequency (RF)
coil for the human head, a rigid mechanical former was
recycled from a disused 1H head birdcage coil. An eight-leg
birdcage coil of band pass topology was constructed with a
capacitance of 289.5 pF (270 pFþ 18 pFþ1.5 pF) and 1000
pF on the legs and on the end ring, respectively, as shown
in Figure 1b. A photograph of the RF birdcage coil is shown
in Figure 1a. The end ring diameter was 305 mm and the leg
length was 300 mm as shown in Figure 1a. The capacitors
used were of 10C package (Dalian Dalicap Technology Co.,
Ltd, Dalian, China). The birdcage coil was driven in quadra-
ture transmit–receive mode. RF measurements were
performed using an Agilent 5061B Network Analyzer (Key-
sight Technologies, Santa Rosa, CA).
The RF power required to achieve a desired flip angle was
calculated based on a standard calibration procedure,
whereby the rate of depletion of polarization of HP 129Xe
resulting from repeated acquisitions using hard RF pulse
within a short time-interval (TR T1) was fit to cosn-1a,
where n is the number of repeated acquisitions and a is the
flip angle for the transmit RF power. To calculate the varia-
tion in flip angle across the coil, a plastic tube with 6 mm
inner diameter was filled with HP 129Xe and positioned
radially within the RF coil as shown in the photograph in
Figure 1c, and the coil was loaded with a standard nickel
chloride (NiCl26H20:H20) phantoms. The length of the tube
was 36 cm, which covered the diameter of the RF coil.
Using a fast spoiled gradient echo sequence with a soft
(Gaussian) RF pulse, with frequency encoding applied
only along one direction (anterior to posterior as shown in
Figure 1c), the flip angle profile along the diameter of the
RF coil was calculated by measuring the depletion of
polarization of the HP 129Xe in each voxel along the length
of the tube as shown in Figure 1d. Acquisition parameters
were: echo time (TE)¼3.6 ms, repetition time (TR)¼ 18.9
ms, matrix¼ 1 (phase)  44 (frequency), slice
thickness¼ 200 mm, number of slices¼ 1, field of view
(FOV)¼ 44 cm, RF pulse duration¼ 800 ms, and the acqui-
sition lasted 800 ms. A total of 39 repeated acquisitions
were performed. T1 relaxation and gas diffusion were both
neglected for the calculation.
MRI Methods
All in vivo NMR with 129Xe experiments were performed
with approval from the UK National Research Ethics
Committee under a protocol for the evaluation of novel
MRI methods for imaging hyperpolarized xenon in the
lungs, brain, and heart of healthy human volunteers.
MRI experiments were performed on a GE whole-body
1.5T SignaVR HDx scanner. All in vivo experiments were
conducted following inhalation of isotopically enriched
xenon (87% 129Xe) from 1 L TedlarVR bags. 129Xe gas was
polarized using spin exchange optical pumping to
around 25% polarization (22). Chemical shift values
were calibrated with respect to the resonance of 129Xe in
the gas-phase measured in a TedlarVR bag positioned at
the isocenter of the scanner. In vivo experiments were
FIG. 1. RF birdcage coil for
129Xe brain MR spectroscopy
and chemical shift imaging. a:
Photograph of the RF birdcage
coil. b: Schematic of the RF
birdcage coil. c: Picture of the
experimental setup for calcula-
tion of flip angle profile. d: 129Xe
NMR signal measured after the
5th, 15th, 25th, and 35th RF
pulses (black lines) indicating
depletion in polarization and the
flip angle profile for a 90 RF
pulse (red line).
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conducted on three healthy male volunteers with the
mean age of 29 years and standard deviation of 3 years.
Wideband Spectroscopy
The xenon gas dose for the acquisition was 1 L. The
acquisition was performed under breath-hold commenc-
ing immediately after the inhalation of the gas and lasted
for 20 s thereafter. After inhalation, the residual gas in
the TedlarVR bag was placed on the neck of the subject to
obtain a reference HP 129Xe gas-phase signal. A total of
20 discrete free induction decays (FIDs) were acquired
with a flip angle of 20 and TR of 1 s. The transmit RF
pulse was a hard pulse with a pulse duration of 500 ms.
The center frequency was set to 197.93 ppm downfield
(17,660,800 Hz) from the 129Xe gas-phase resonance and
the receiver bandwidth was 674.16 ppm (11.9 kHz). The
spectral resolution was 0.16 ppm (2.9 Hz) with 4096 sam-
pling points in the spectrum. All 20 acquired complex
spectra were averaged to improve the signal-to-noise ratio
(SNR). No spectral line broadening filters were applied.
High Resolution Spectroscopy
For high resolution spectroscopy, data acquisition was
performed during a 20 s breath-hold, commencing 4 s
after inhalation of a 1 L dose of xenon gas. Ten discrete
FIDs were acquired with a TR of 2 s and a flip angle of
45. The transmit RF pulse was a hard pulse with a
pulse duration of 500 ms. The center frequency was set
to 197.93 ppm downfield (17,660,800 Hz) from the 129Xe
gas-phase resonance and the receiver bandwidth was
136.09 ppm (2403 Hz). The spectral resolution was 0.033
ppm (0.58 Hz) with 4096 sampling points in the spec-
trum. All 10 acquired complex spectra were averaged
and no spectral line broadening filters were applied.
Chemical Shift Imaging
To spatially localize the 129Xe spectral peaks anatomi-
cally in the human brain, 2D CSI was conducted by
applying phase-encoding in the anterior–posterior and
right–left directions for axial-plane CSI, anterior–
posterior and superior–inferior directions for sagittal-
plane CSI, and right–left and superior–inferior directions
for coronal-plane CSI. FIDs were acquired for each
phase-encoding step using a pulse-acquire sequence
without slice selection. The transmit RF pulse was as
described earlier. The center frequency was set to 197.93
ppm downfield (17,660,800 Hz) from the 129Xe gas-phase
resonance and the receiver bandwidth was 136.05 ppm
(2403 Hz). The spectral resolution was 2.1 ppm (37 Hz)
with 64 sampling points per spectrum. The flip angle
was 10, and the TR was 45 ms. For a matrix size of 12
 12 and a FOV of 24 cm, 144 phase-encoded spectra
were acquired with an effective in-plane spatial resolu-
tion of 20 mm  20 mm. The acquisition was performed
under breath-hold, commencing 16 s after the inhalation
of a 1 L dose of xenon gas and lasted for 6.5 s thereafter.
No spectral line broadening filters were applied.
For anatomical reference, 1H MR images were acquired
(in each of the three anatomical planes) using an inversion
recovery gradient echo pulse sequence in a separate scan
with the same FOV as the 129Xe CSI acquisition. The imag-
ing parameters were: TE¼5.2 ms, inversion time¼ 450
ms, TR¼ 12.4 ms, flip angle¼ 20, bandwidth¼ 15.6 kHz,
slice thickness¼1.6 mm and matrix size¼512  512. For
the purpose of assignment of a particular resonance to a
particular brain compartment, the 129Xe chemical shift
images were superimposed on the corresponding anatomi-
cal reference 1H images. Each pixel of the HP 129Xe CSI
represents the maximum value of a particular chemical
shift peak at that spatial location. An image intensity
threshold determined by visual inspection was applied to
the 2D CSI images of dissolved HP 129Xe to eliminate back-
ground noise. The threshold for each of the 2D CSI images
were determined and applied individually.
RESULTS
RF Coil and Calibration
The quality factor (Q) of the birdcage RF coil in the
unloaded condition was 270 and in the loaded condition
was 86. The ratio of the Q factor in unloaded to loaded
condition was, therefore, 3.1. The isolation (transfer coef-
ficient, Sij; i 6¼jð Þ) between the in-phase and the quadrature-
phase ports of the RF birdcage coil was lower than 15
dB. Figure 1d shows the measured 129Xe NMR signal after
the 5th, 15th, 25th, and 35th RF pulse with frequency
encoding applied only along one direction (anterior–pos-
terior), indicating depletion of polarization. For a nominal
90 RF pulse, the standard deviation of the flip angle
measured across the diameter of the coil was 5.9 (6.56%)
and the flip angle profile is shown in Figure 1d.
Spectroscopy
An averaged spectrum of HP 129Xe dissolved in the
human head acquired with a wide receiver bandwidth is
shown in Figure 2a. The spectrum exhibits two distinct
peaks near 0 ppm assigned to 129Xe in the gaseous
phase. Near the center frequency of the spectrum, five
distinct dissolved 129Xe peaks from the human head can
be observed, at 188.4 ppm, 192.7 ppm, 195.6 ppm, 199.6
ppm, and 217.2 ppm.
An averaged whole head spectrum acquired from HP
129Xe dissolved in the human head with high spectral
resolution (0.033 ppm) is shown in Figure 2b. The spec-
trum exhibits five distinct peaks: 187.2 ppm, 192.5 ppm,
195.4 ppm, 199.0 ppm, and 216.2 ppm.
Chemical Shift Imaging
To demonstrate that the SNR of spatially resolved spec-
tra from the CSI experiment of the human head are suffi-
cient, example spectra (at arbitrary locations) for each of
the anatomical planes are shown in Figure 3. It can be
observed, that the SNR of these spatially resolved spectra
are sufficient to enable distinction of the peaks at 188
ppm, 192 ppm, 196 ppm, 200 ppm, and 217 ppm, and
that the signal amplitudes are clearly prominent above
the noise floor. Spatially resolved spectra in all the three
imaging planes superimposed on corresponding anatomi-
cal 1H images are shown in Figure 4.
Chemical shift images corresponding to 129Xe NMR
peak from the head at 188 ppm, 192 ppm, 196 ppm, 200
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ppm, and 217 ppm, superimposed (in color) on corre-
sponding anatomical 1H images are shown in Figures 5a–
c,e,f. Figure 5d shows the spectrum from Figure 2b split
into its constituent real and imaginary parts after zeroth
order phase-correction using the 195.4 ppm (gray matter)
peak as a reference. The full width half maximum of the
peak at 195.4 ppm (gray matter) in Figure 5d is 36 Hz.
DISCUSSION
In Figure 2a, the peak at 0.7 ppm can be attributed to
residual gas in the TedlarVR bag placed on the subject’s
neck. The 129Xe gas-phase resonance being shifted by 0.7
ppm (instead of 0 ppm) suggests B0 variation of 1 mT due
to the TedlarVR bag not being positioned at the isocenter of
the magnet combined with bulk susceptibility shifts related
to the subject’s head. Similarly, we postulate that the peak at
2.8 ppm is related to detection of 129Xe gas in the smaller
airways of the lungs in the stray field of the RF coil. The up-
field (negative) chemical shift of this 129Xe gas in the smaller
airways of the lungs could be due to a combination of
effects, including; bulk magnetic susceptibility shift effects
(5), the chemical shift associated with mixing with oxygen
(23) and the fact that while an average adult head is posi-
tioned at the isocenter, the lungs lie further away from the
isocenter at a lower static magnetic field strength than the
isocenter and would experience a lower Larmor frequency.
The chemical shift values reported in Figure 3 are mar-
ginally different from the values reported in Figure 2,
most likely due to the considerable difference in spectral
resolution between the two acquisitions. In addition, it
can be observed that some of the five peaks (from Figure
2) are absent in some of the spectra in Figure 3. This
indicates that the particular biochemical compartment
giving rise to a specific chemical shift value is not pres-
ent at that particular voxel location.
From the anatomical location of the 129Xe NMR peaks in
the chemical shift images superimposed on corresponding
1H images in Figure 5, we propose the assignment of each
individual peak to a particular compartment of the head
as follows:
FIG. 2. In vivo magnitude spectra of HP 129Xe dissolved in the human head. a: Spectrum with wide bandwidth (674.16 ppm) and a
spectral resolution of 0.16 ppm. b: Spectrum with a narrow bandwidth (136.09 ppm) and a higher spectral resolution of 0.033 ppm.
Note: (a) and (b) represent two separate acquisitions. Subject: male 31 years old.
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188 ppm
From Figure 5a, the peak at 188 ppm appears to be most
intense in the anterior region of the axial plane image.
The sagittal plane image indicates that most of the signal
from this peak arises from regions below the eyes, above
the jawline and between the nose and ears. In the coronal
FIG. 3. Individual spectra acquired in a 2D chemical shift imaging
experiment at arbitrary locations in the head. a: Axial plane spec-
trum from the left center of the head, showing peaks at 188 ppm,
194 ppm, and 217 ppm. b: Sagittal plane spectrum from the ante-
rior inferior part of the head, showing peaks at 189 ppm, 196
ppm, and 200 ppm. c: Coronal plane spectrum from the superior
center of the head, showing peaks at 192 ppm and 196 ppm. The
peaks have been labeled to indicate the compartment of the head
with which they are assigned (see the Discussion section). Sub-
ject: male 31 years old.
FIG. 4. Spatially resolved 129Xe spectra of the head in all the three
imaging planes superimposed on corresponding anatomical 1H
images. a: Axial plane. B: Sagittal plane. C: Coronal plane. Sub-
ject: male 31 years old.
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plane image, it is evident that the signal intensity is
approximately symmetric on both right and left sides of
the head. In addition, this image shows that some contri-
bution arises from a location at the midbrain. We allocate
the peak at 188 ppm to HP 129Xe dissolved in soft muscu-
lar tissue in cheek and midbrain.
FIG. 5. The 2D chemical shift images of spatially resolved peaks from 129Xe in the human head, superimposed (in color) on 1H reference
images (gray scale) in all the three anatomical planes. a: 188 ppm - tissue in the cheek muscle and the midbrain/brainstem. b: 192 ppm
- white matter and cartilaginous soft-tissue. c: 196 ppm - gray matter. e: 200 ppm - body interstitial fluid/plasma, fat tissue outside the
brain and cerebrospinal fluid. f: 217 ppm - red blood cells. The threshold for each of the 2D CSI images were determined and applied
individually. Color bars represent arbitrary units normalized to the maximum NMR signal intensity of hyperpolarized 129Xe dissolved in
the gray matter. d: Phase-corrected real and imaginary parts of the spectrum from Figure 2b, showing HP 129Xe dissolved in the human
head in vivo with a spectral resolution of 0.033 ppm and a bandwidth of 136.09 ppm. Subject: male 31 years old.
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192 ppm
From Figure 5b, it can be observed that the peak at 192
ppm appears to predominantly arise from 129Xe dissolved
in the brain. In the axial plane, the peak at 192 ppm is
most intense in the brain with some evidence of tracts.
Similarly, in the coronal plane image, the peak at 192 ppm
appears to be most intense in the central brain, again with
some evidence of tracts. In the sagittal plane image, a con-
tribution to the 192 ppm peak can be observed from 129Xe
in the region of the nasal cavity. Thus, it can be postulated
that the peak at 192 ppm corresponds to HP 129Xe dis-
solved in white matter (Commissural and Projection tracts)
and cartilaginous soft-tissue.
196 ppm
Figure 5c shows that the 129Xe peak at 196 ppm is pre-
dominantly localized to the brain; it can be clearly seen
in images from the all three anatomical planes that the
peak not only emanates from the brain, but does not
appear anywhere else. Thus it can be concluded that the
peak at 196 ppm corresponds to HP 129Xe dissolved in
the gray matter.
Unlike the case of xenon gas in an isolated bag, in the
human brain in vivo, 129Xe will undergo diffusive chem-
ical exchange with other compartments of the brain that
come in to contact with each other (such as cerebral
blood, interstitial fluid, and cerebrospinal fluid). Exis-
tence of any such chemical exchange will broaden the
line-width of the NMR peaks of the compartments under
exchange. Nevertheless, under these conditions the full
width half maximum of a particular spectral peak will
provide a lower limit estimate of the T2 relaxation time
from a given voxel. The full width half maximum of 36
Hz for the gray matter peak in Figure 5d corresponds
to T2  8.8 ms.
200 ppm
From Figure 5e, the peak at 200 ppm appears to originate
from 129Xe located in the anterior region of the head, as
seen from the axial plane image. In the sagittal plane
image, most of the signal appears to be from regions
among the eyes, nose, and ears, and extends below
toward the jaw. In the coronal plane image, the signal
appears to arise from the center of the head in the right–
left direction. In all the three anatomical planes, the sig-
nal appears to coincide with the location of the ven-
tricles. Thus, the peak at 200 ppm is likely from HP
129Xe dissolved in body interstitial fluid/plasma, fat tis-
sue outside the brain, and cerebrospinal fluid.
217 ppm
From Figure 5f, in all three anatomical planes, the only
location where the peak at 217 ppm shows considerable
signal intensity is at the location of the Circle of Willis.
This peak at 217 ppm can, therefore, be allocated to HP
129Xe dissolved in the red blood cells. It is worth noting
that this peak is broader than the others, most probably
due to the diffusive chemical exchange between 129Xe
dissolved in various compartments, and to the fact that
blood oxygenation will vary across the head, resulting in
a dispersion of the chemical shift due to difference in
the oxygenation state of the hemoglobin (24).
The assignment of the chemical shift values with the
particular biochemical environments as described above
FIG. 6. Chemical shift images of the spectral peak at 195.5 ppm assigned to 129Xe dissolved in gray matter: male subject 25 years old
(a) and male subject 30 years old (c). Spectra (real part) of HP 129Xe dissolved in the human brain in vivo acquired with same acquisition
parameter as high resolution spectrum: male subject 25 years old (b) and male subject 30 years old (d).
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is supported by earlier studies, which include in vivo
reports of 129Xe in the rat and human head and in vitro
studies of 129Xe dissolved in human blood. These earlier
studies suggested the following peak assignments: 187.2
ppm, muscle (19–21); 192.7 ppm, white matter (and soft-
tissue in this study) (18–21); 195.6 ppm, gray matter
(18–21); 199.6 ppm, aqueous solution (cerebrospinal
fluid, plasma, and interstitial fluid in this study)
(10,11,24–26) and fat/lipid tissue outside the brain
(19,20); and 217.2 ppm, red blood cells (4,10,24,26).
The peaks seen in whole brain spectroscopy and their
anatomical distribution from CSI, were found to be con-
sistent between the subjects as shown in Figure 6. The
SNR of the obtained spectra was found to be somewhat
variable between the subjects. As SNR is limited by the
quantity and polarization of 129Xe delivered to the brain
by the systemic blood circulation, any variability in the
polarization of the SEOP process, gas dose inhaled or T1
losses related to different lung-to-brain transit times will
affect the observed SNR. Assessment of these factors,
their variability and their effect on measured spectro-
scopic SNR of dissolved 129Xe in the brain is the subject
of future work.
On closer inspection of Figure 2b, it can be seen that
the peak at 187.2 ppm appears to be comprised of two
closely spaced peaks at 186.7 ppm and 187.7 ppm which
requires further investigation. In addition, a peak at 190.6
ppm can be observed in both Figure 2a inset and 2b
which also requires further investigation in future work.
CONCLUSIONS
This is the first time that five distinct 129Xe NMR peaks
have been observed in the human head in vivo and we
believe this to be the first report of 129Xe CSI in the
human head in vivo at 1.5T. Although earlier studies
evidenced the presence of 5 129Xe NMR peaks in the rat
head (19,20), only two or three peaks have been previ-
ously detected from 129Xe in the human head from spec-
tra of significantly lower SNR and spectral resolution
than those in this study (4,18). Our results should pro-
vide a useful reference for future 129Xe NMR spectros-
copy studies of the human brain. Furthermore, the
methods established here may be directly applied to
quantify the dynamics of xenon uptake into the human
brain and probe the potential pathophysiological changes
induced by functional abnormalities.
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